K233242

Substantially Equivalent

Atellica® CH High Sensitivity C-Reactive Protein 2 (hCRP2)

Applicant: Siemens Healthcare Diagnostics, Inc.
Product code: NQD
Advisory panel: Immunology
Date received: 2023-09-28
Decision date: 2024-01-18
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Newark, DE, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.